Beginning July 1, 2026, state funds support opioid and substance-use services, while agencies and advisers follow new spending, review, and syringe-recovery instructions.
Fiscal year 2027 funding supports opioid-use-disorder services, staff, recovery coaches, and recovery housing. Some earlier appropriations return to the fund, and the Health Department must report spending quarterly.
Up to $1.1 million may be considered for an overdose prevention center during fiscal year 2027, but only if a site is secured, prepared, and operating or nearly ready.
Most new opioid-fund proposals would be paused in fiscal year 2028 while previously funded programs are reviewed. An exception covers programs expected to receive annual funding.
The Health Department must recommend statewide syringe-recovery models by December 15, 2026. Fiscal year 2027 funding also supports substance-use services and requires yearly spending estimates.
The act provides fiscal year 2027 money from the Opioid Abatement Special Fund for opioid-use-disorder programs, services, and staff. Funding may support outreach and case management staff, peer recovery center coaches, recovery residence beds, and other opioid-use-disorder programming. The money comes from the Opioid Abatement Special Fund. The Department of Health must report quarterly to the General Assembly on fiscal year 2027 spending. Earlier appropriations for satellite locations, wound care, and stabilization beds return to the Special Fund. These funding and reporting provisions apply to fiscal year 2027, beginning July 1, 2026.
The General Assembly is directed to consider up to $1.1 million for an overdose prevention center during the fiscal year 2027 budget adjustment process. The possible funding concerns an overdose prevention center in Vermont. Funding depends on finding that a location has been obtained, is being prepared for use, and is operating or will soon operate. The text states that the General Assembly intends to consider the funding; it does not guarantee that the money will be provided. The funding would be considered during the fiscal year 2027 budget adjustment process.
The Opioid Settlement Advisory Committee must stop accepting most new Special Fund proposals in fiscal year 2028 and review previously funded programs. The restriction covers new proposals seeking money from the Opioid Abatement Special Fund, with an exception for programs that earlier law expected to receive annual funding. The review must consider program results, long-term sustainability, and whether the Special Fund is the appropriate funding source. The review will help guide recommendations for fiscal year 2029 and later. The committee must consult the Health Equity Advisory Commission and the Attorney General, and applicants must provide sustainability plans for funding proposals. The proposal restriction applies in fiscal year 2028; the reviews inform recommendations for fiscal year 2029 and later.
The Department of Health must submit a statewide syringe-recovery plan, and the act provides fiscal year 2027 money for substance-use-disorder programs and services. The plan must address one or more syringe-recovery models and reporting by syringe-service providers on returned or otherwise collected syringes. The Health Department must include recommendations for implementing the models throughout Vermont. The department must report proposed spending from the Substance Misuse Prevention Special Fund in its yearly budget presentation, including expected money left unallocated at year-end. The syringe-recovery plan is due December 15, 2026; the funding applies to fiscal year 2027, beginning July 1, 2026.
No hearings or votes scheduled.